Recombinetics Obtains $250,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e80bb6b-c1f2-4374-89a2-a6680a78d054&Preview=1 -
Date
1/23/2013 -
Company Name
Recombinetics -
Mailing Address
2575 University Avenue West Saint Paul, MN 55114 -
Company Description
At Recombinetics, we use unique precision genetics technologies to provide scientists who study persistent health risks — obesity, diabetes, cancer, and high heart disease –with the research tools they need to understand and combat disease. -
Website
http://www.recombinetics.com -
Transaction Type
Venture Equity -
Transaction Amount
$250,000 -
Transaction Round
Series A -
Proceeds Purposes
Recombinetics hopes to ramp up production to 600 diseased pigs per year by 2016. -
M&A Terms
-
Venture Investor
Undisclosed
